null
ChEBI ID: 37290
| Member | Definition | Role |
|---|---|---|
| 5-formamidoimidazole-4-carboxamide ribotide | 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | |
| aica ribonucleotide | A 1-(phosphoribosyl)imidazolecarboxamide that is acadesine in which the hydroxy group at the 5' position has been converted to its monophosphate derivative. | AICA ribonucleotide |
| n(1)-((5'-phosphoribulosyl)formimino)-5-aminoimidazo-4-carboxamide ribonucleotide | 5-[(5-phospho-1-deoxy-D-ribulos-1-ylimino)methylamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide | |
| saicar | A 1-(phosphoribosyl)imidazolecarboxamide resulting from the formal condesation of the darboxy group of 5-amino-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazole-4-carboxylic acid with the amino group of L-aspartic acid. | SAICAR |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 24 (1.83) | 18.7374 |
| 1990's | 72 (5.50) | 18.2507 |
| 2000's | 476 (36.36) | 29.6817 |
| 2010's | 668 (51.03) | 24.3611 |
| 2020's | 69 (5.27) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 9 (0.67%) | 5.53% |
| Reviews | 27 (2.02%) | 6.00% |
| Case Studies | 9 (0.67%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 1,291 (96.63%) | 84.16% |